Dysgeusia and health-related quality of life of cancer patients receiving chemotherapy: A cross-sectional study

Citations Over TimeTop 10% of 2017 papers

Abstract

The aim of the study was to evaluate taste disorders in patients receiving chemotherapy and to assess the impact of dysgeusia on patients' health-related quality of life (HRQOL). A total of 289 patients with a diagnosis of malignant solid or haematological cancer undergoing chemotherapy completed a questionnaire assessing dysgeusia and HRQOL. Sixty-four per cent of patients developed dysgeusia after and during chemotherapy. A statistically significant correlation was found between type of cancer and dysgeusia (p = .012), moreover a statistically significant association was found between type of chemotherapy and occurrence of dysgeusia (p = .031). Patients with dysgeusia had a worse overall HRQOL than those who did not have dysgeusia, and the association between HRQOL and dysgeusia was also statistically significant (p = .003). Patients with dysgeusia had a higher probability of having a worse HRQOL (p = .002). In line with previous studies, we observed a significant correlation between chemotherapy and dysgeusia. Furthermore, this study found that cancer patients with dysgeusia have a lower quality of life. In particular the domains "role," "social aspect," "nausea-vomiting" and "appetite" are most influenced by dysgeusia. Improving the communication and information to patients considered at higher risk of developing dysgeusia can have a positive impact on patients' quality of life.

Related Papers

• → Pathogenesis of dysgeusia in COVID-19 patients: a scoping review.(2021)57 cited
• → Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer(2013)47 cited
• → Evaluation of Chemotherapy-induced Dysgeusia in Patients With Gastrointestinal Cancer: A Pilot Study(2023)7 cited
• → Incidence and Treatment of Dysgeusia in Patients with Glossodynia(2002)25 cited
• → Dysgeusia and COVID-19: the Importance of the Dentist in the Diagnostic(2021)2 cited